Oruka Therapeutics, Inc. (ORKA) analyst actions
Rating and price-target actions on ORKA in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the ORKA overview →
1 measured ORKA analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Oruka Therapeutics Announces Positive Interim Phase 1 Data for ORKA-002 and Initiation of EVERLAST-B Trial of ORKA-001 | Press release | -2.31% | +10.63% |
Keep exploring
More ORKA: earnings → · SEC filings → · ORKA overview →